Chemical Compound Review:
Benzeneoxide 7-oxabicyclo[4.1.0]hepta-2,4- diene
Synonyms:
Benzene oxide, CHEMBL297630, CCRIS 2979, AG-D-94626, Arene oxide, ...
- Genetic predisposition to phenytoin-induced birth defects. Strickler, S.M., Dansky, L.V., Miller, M.A., Seni, M.H., Andermann, E., Spielberg, S.P. Lancet (1985)
- Anticonvulsant-induced aplastic anemia: increased susceptibility to toxic drug metabolites in vitro. Gerson, W.T., Fine, D.G., Spielberg, S.P., Sensenbrenner, L.L. Blood (1983)
- NIH shift in the hydroxylation of aromatic compounds by the ammonia-oxidizing bacterium Nitrosomonas europaea. Evidence against an arene oxide intermediate. Vannelli, T., Hooper, A.B. Biochemistry (1995)
- Increased microsomal irreversible binding of phenytoin by valproic acid. Wang, S.L., Lai, M.L., Huang, J.D. Biochem. Pharmacol. (1991)
- Cross-sensitivity and the anticonvulsant hypersensitivity syndrome. Moss, D.M., Rudis, M., Henderson, S.O. The Journal of emergency medicine. (1999)
- Tumor-initiating activity of benz[c]acridine and twelve of its derivatives on mouse skin. Levin, W., Wood, A.W., Chang, R.L., Kumar, S., Yagi, H., Jerina, D.M., Lehr, R.E., Conney, A.H. Cancer Res. (1983)
- Characterization of pulmonary arene oxide biotransformation using the perfused rabbit lung. Smith, B.R., Plummer, J.L., Ball, L.M., Bend, J.R. Cancer Res. (1980)
- Differential stereoselectivity on metabolism of triphenylene by cytochromes P-450 in liver microsomes from 3-methylcholanthrene- and phenobarbital-treated rats. Thakker, D.R., Boehlert, C., Mirsadeghi, S., Levin, W., Ryan, D.E., Thomas, P.E., Yagi, H., Pannell, L.K., Sayer, J.M., Jerina, D.M. J. Biol. Chem. (1988)
- 4-Hydroxyphenylpyruvate dioxygenase: a hybrid density functional study of the catalytic reaction mechanism. Borowski, T., Bassan, A., Siegbahn, P.E. Biochemistry (2004)
- Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions. Gaedigk, A., Spielberg, S.P., Grant, D.M. Pharmacogenetics (1994)
- Pharmacokinetics of R-enantiomeric normephenytoin during chronic administration in epileptic patients. Bourgeois, B.F., Küpfer, A., Wad, N., Egli, M. Epilepsia (1986)
- Relation of in vivo drug metabolism to stereoselective fetal hydantoin toxicology in mouse: evaluation of mephenytoin and its metabolite, nirvanol. Wells, P.G., Küpfer, A., Lawson, J.A., Harbison, R.D. J. Pharmacol. Exp. Ther. (1982)
- Effect of glucose-6-phosphate dehydrogenase deficiency on the benz(a)pyrene toxicity for in vitro cultured human skin fibroblasts. Pirisi, L., Pascale, R., Daino, L., Frassetto, S., La Spina, V., Zanetti, S., Gaspa, L., Ledda, G.M., Garcea, R., Feo, F. Res. Commun. Chem. Pathol. Pharmacol. (1982)
- The hydroxylation, dechlorination, and glucuronidation of 4,4'-dichlorobiphenyl (4-DCB) by human hepatic microsomes. Schnellmann, R.G., Volp, R.F., Putnam, C.W., Sipes, I.G. Biochem. Pharmacol. (1984)
- The use of protein adducts to investigate the disposition of reactive metabolites of benzene. Rappaport, S.M., McDonald, T.A., Yeowell-O'Connell, K. Environ. Health Perspect. (1996)
- Imipramine-induced inactivation of a cytochrome P450 2D enzyme in rat liver microsomes: in relation to covalent binding of its reactive intermediate. Masubuchi, Y., Igarashi, S., Suzuki, T., Horie, T., Narimatsu, S. J. Pharmacol. Exp. Ther. (1996)
- Metabolism of lamotrigine to a reactive arene oxide intermediate. Maggs, J.L., Naisbitt, D.J., Tettey, J.N., Pirmohamed, M., Park, B.K. Chem. Res. Toxicol. (2000)
- Enantioselectivity of microsomal epoxide hydrolase toward arene oxide substrates. Armstrong, R.N., Kedzierski, B., Levin, W., Jerina, D.M. J. Biol. Chem. (1981)
- Hydroxylation and methylthiolation of mono-ortho-substituted polychlorinated biphenyls in rats: identification of metabolites with tissue affinity. Haraguchi, K., Kato, Y., Kimura, R., Masuda, Y. Chem. Res. Toxicol. (1998)
- cis-Dihydrodiol, arene oxide and phenol metabolites of dictamnine: key intermediates in the biodegradation and biosynthesis of furoquinoline alkaloids. Boyd, D.R., Sharma, N.D., O'Dowd, C.R., Carroll, J.G., Loke, P.L., Allen, C.C. Chem. Commun. (Camb.) (2005)
- Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase. Wells, P.G., Zubovits, J.T., Wong, S.T., Molinari, L.M., Ali, S. Toxicol. Appl. Pharmacol. (1989)
- Human biotransformation of bropirimine. Characterization of the major bropirimine oxidative metabolites formed in vitro. Wynalda, M.A., Hauer, M.J., Wienkers, L.C. Drug Metab. Dispos. (1998)
- An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro. Pirmohamed, M., Kitteringham, N.R., Guenthner, T.M., Breckenridge, A.M., Park, B.K. Biochem. Pharmacol. (1992)
- Purification and biochemical characterization of the rabbit pulmonary glutathione S-transferase: stereoselectivity and activity toward pyrene 4,5-oxide. Serabjit-Singh, C.J., Bend, J.R. Arch. Biochem. Biophys. (1988)
- 2,2',5,5'-Tetrachlorobiphenyl: isolation and identification of metabolites generated by rat liver microsomes. Preston, B.D., Allen, J.R. Drug Metab. Dispos. (1980)
- Identification of benzene oxide as a product of benzene metabolism by mouse, rat, and human liver microsomes. Lovern, M.R., Turner, M.J., Meyer, M., Kedderis, G.L., Bechtold, W.E., Schlosser, P.M. Carcinogenesis (1997)
- Identification of an arene oxide metabolite of 2,2',5-5'-tetrachlorobiphenyl by gas chromatography-mass spectroscopy. Forgue, S.T., Allen, J.R. Chem. Biol. Interact. (1982)
- Phenytoin embryopathy: effect of epoxide hydrolase inhibitor on phenytoin exposure in utero in C57BL/6J mice. Hartsfield, J.K., Holmes, L.B., Morel, J.G. Biochem. Mol. Med. (1995)